It was wonderful to celebrate Symbio’s 20th anniversary with so many people at the 2022 AAD Annual Meeting in Boston.
Over 200 clinical studies, 85,000 subjects and 55 FDA approvals since our founding, Symbio has proved to consistently deliver high-quality service and unwavering collaboration with its sponsors. As one of the few leading CROs that are privately owned, Symbio’s leadership team takes great pride in operating solely in the best interests of its clients, free of the outside influences and pressures often experienced by organizations with venture capitalists or governing boards.
IF WE DIDN’T GET TO CONNECT AT AAD, REACH OUT TO US NOW USING THE FORM BELOW OR CONTACT US DIRECTLY:
Richard Panico, President, (631) 474-8531 x12, rpanico@symbioresearch.com
Chad Troller, Director, Client Services, (631) 403-5123, ctroller@symbioresearch.com
Connect with Us!
Fill out the form below to reach out to us.
